Investors with an eye on the healthcare sector might find Surgery Partners, Inc. (NASDAQ: SGRY) an intriguing opportunity, especially considering its potential upside of 35.36% based on current analyst targets...
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a dynamic player in the healthcare sector with a focus on biotechnology, continues to capture investor interest with its innovative approach to treating rare..
Merus N.V. (NASDAQ: MRUS), a clinical-stage biotechnology firm based in the Netherlands, is garnering significant attention in the investor community. With a promising pipeline of innovative bispecific antibody therapeutics targeting..
Investors looking for opportunities in the healthcare sector should take a closer look at Acadia Healthcare Company, Inc. (NASDAQ: ACHC). With a market cap of $1.95 billion, this company specializes..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a dynamic player in the biotechnology sector, has been making waves with its innovative approach to treating rare and orphan diseases. Headquartered in Foster City,..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biopharmaceutical industry, has carved a niche with its focus on developing and commercializing medicines targeting central nervous system (CNS) disorders..
CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of biotechnology innovation, carving a niche in the dynamic sector with its revolutionary CRISPR/Cas9 gene-editing platform. With a current market cap..
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands as a noteworthy player in the biotechnology sector, with a market capitalization of $3.53 billion. This commercial-stage biopharmaceutical company is headquartered in Stamford, Connecticut,..
Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector with a focus on health information services, presents an enticing opportunity for investors. With a market capitalization..
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling opportunity for investors looking to tap into the burgeoning biotechnology sector, particularly in the niche field of rare and ultra-rare genetic diseases...
Immunovant, Inc. (NASDAQ: IMVT) is capturing investor attention with its compelling potential upside of 180.08%, according to recent analyst ratings. As a clinical-stage biotechnology company, Immunovant is focused on developing..
Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is drawing significant attention from investors with its impressive potential for growth and innovation in the field of immunotherapies...
For investors seeking opportunities in the healthcare sector, Alvotech (NASDAQ: ALVO) presents a compelling case with a notable potential upside of 92.72%. This Luxembourg-based company is carving out a niche..
Scholar Rock Holding Corporation (NASDAQ: SRRK), a dynamic player in the biotechnology sector, has piqued investor interest with its promising pipeline in the healthcare industry. Headquartered in Cambridge, Massachusetts, this..
Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to tackling obesity and related disorders. Headquartered in New York, Metsera focuses..
Amedisys Inc (AMED), a prominent player in the healthcare sector, continues to attract attention from investors seeking opportunities in the medical care facilities industry. With a market capitalization of $3.19..
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) has been a standout performer in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.34 billion, this U.S.-based company..
